A recent post shared on X (formerly Twitter) has sparked a debate about public etiquette and civic sense in India, ...

Benson, a 6-foot-3 Illinois commit, was previously named a finalist for the prestigious Ms. Basketball award. She averaged 19 ...

In this episode of "Shelf Portrait," comedian and host Lilly Singh gives Marie Claire a look at her eye-catching, topsy-turvy bookshelves filled with books by several of her favorite South Asian ...

Eli Lilly has officially launched Mounjaro (Tirzepatide) in India, making it the first major weight-loss and diabetes drug of its kind to enter the country. This move places Eli Lilly ahead of rival ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the pharmaceutical giant Eli Lilly on Thursday announcing the launch of tirzepatide ...

Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...

Weight loss drugs such as Mounjaro help the body manage blood sugar more effectively, make one feel less hungry, and slow digestion, so the person feels full longer. Mounjaro, chemically known as ...

Dr Reddy’s Laboratories is also working on a generic version of Wegovy. (Image/Getty) US pharma major Eli Lilly on Thursday launched its global bestseller anti-obesity and diabetes drug Mounjaro ...

Dr. Sukhvinder Singh Saggu, Director Minimal Access, GI & Bariatric Surgery at the CK Birla Hospital, Delhi said: "Eli Lilly has launched Mounjaro (tirzepatide) in India, a once-weekly injectable ...

The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors, representing an innovative approach to metabolic health. Prices range from Rs3,500 to Rs4,375 per vial.

American pharmaceutical major Eli Lilly and Company on Thursday (March 20, 2025) launched its diabetes and obesity management drug Mounjaro (tirzepatide) in India. The company launched the drug in ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight ...